C World Wide Group Holding A Coherus Bio Sciences, Inc. Transaction History
C World Wide Group Holding A
- $8.06 Billion
- Q1 2025
A detailed history of C World Wide Group Holding A transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, C World Wide Group Holding A holds 1,928,464 shares of CHRS stock, worth $1.56 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,928,464
Previous 1,928,464
-0.0%
Holding current value
$1.56 Million
Previous $2.66 Million
41.53%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding CHRS
# of Institutions
123Shares Held
64.5MCall Options Held
96.6KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$9.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$9.03 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.26 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.13 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.46 Million0.11% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $63M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...